| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Tsvetelina Velikova | |
| P2860 | cites work | Eosinophilic Esophagitis: An Evidence-Based Approach to Therapy | Q26751412 |
| An Overview of the Diagnosis and Management of Eosinophilic Esophagitis | Q26764785 | ||
| Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. | Q30234446 | ||
| Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease | Q34003041 | ||
| Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota | Q34518075 | ||
| Epigenetic regulation of the IL-13-induced human eotaxin-3 gene by CREB-binding protein-mediated histone 3 acetylation. | Q34787101 | ||
| Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation | Q34892555 | ||
| A pilot study of omalizumab in eosinophilic esophagitis | Q35195626 | ||
| Topical steroids in eosinophilic esophagitis: Systematic review and meta-analysis of placebo-controlled randomized clinical trials | Q35877296 | ||
| Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis | Q36113580 | ||
| Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids. | Q36212850 | ||
| Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. | Q36553408 | ||
| Topical Steroid Therapy for the Treatment of Eosinophilic Esophagitis (EoE): A Systematic Review and Meta-Analysis. | Q36751852 | ||
| Successful treatment of eosinophilic esophagitis with ciclesonide | Q37275416 | ||
| Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels | Q37358879 | ||
| Review article: oesophageal dilation in adults with eosinophilic oesophagitis | Q37841683 | ||
| Eosinophilic esophagitis: update on clinicopathological manifestations and pathophysiology | Q37876148 | ||
| ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). | Q38097271 | ||
| Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. | Q38188754 | ||
| Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies | Q38618644 | ||
| 2015 David Y. Graham Lecture: The First Two Decades Of Eosinophilic Esophagitis-From Acid Reflux To Food Allergy | Q38805650 | ||
| Diagnosis and treatment of eosinophilic esophagitis in clinical practice | Q39155749 | ||
| Pathophysiology of Eosinophilic Esophagitis | Q40114032 | ||
| Adrenal Insufficiency after Chronic Swallowed Glucocorticoid Therapy for Eosinophilic Esophagitis. | Q41034460 | ||
| The outcome of patients with oesophageal eosinophilic infiltration after an eight-week trial of a proton pump inhibitor | Q42622855 | ||
| Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis | Q43686203 | ||
| Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children | Q44471652 | ||
| Rapidly increasing incidence of eosinophilic esophagitis in a large cohort | Q45110756 | ||
| Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. | Q45811536 | ||
| Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis. | Q46031657 | ||
| Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia | Q46374558 | ||
| Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis | Q46789131 | ||
| Eosinophilic Esophagitis: Pathophysiology and Definition | Q47565377 | ||
| Pharmacologic Treatment of Eosinophilic Esophagitis: An Update | Q47617305 | ||
| Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand? | Q47710265 | ||
| Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial | Q48509747 | ||
| Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 study. | Q48619078 | ||
| Eosinophilic esophagitis: update on management and controversies | Q50043462 | ||
| Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. | Q51782562 | ||
| Diagnosis and Treatment of Eosinophilic Esophagitis. | Q52760718 | ||
| Escalating incidence of eosinophilic esophagitis: A 20-year prospective, population-based study in Olten County, Switzerland | Q58019861 | ||
| Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies | Q58616088 | ||
| Anti–TNF-α (infliximab) therapy for severe adult eosinophilic esophagitis | Q61959752 | ||
| Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis | Q84364243 | ||
| Four-food group elimination diet for adult eosinophilic esophagitis: A prospective multicenter study | Q85222740 | ||
| The natural history of steroid-naïve eosinophilic esophagitis in adults treated with endoscopic dilation and proton pump inhibitor therapy over a mean duration of nearly 14 years | Q87615532 | ||
| Eosinophilic Esophagitis | Q93354745 | ||
| P433 | issue | 1 | |
| P921 | main subject | eosinophilic esophagitis | Q2057356 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 27-33 | |
| P577 | publication date | 2019-04-12 | |
| P1433 | published in | Przegląd Gastroenterologiczny | Q26841820 |
| P1476 | title | Challenges and updates in the management of eosinophilic esophagitis | |
| P478 | volume | 15 |
Search more.